AllAnalyst Report
logoMorningstarMarch 14, 2024

Alcon Inc.: Alcon's Innovation and Strategy Sparks Further Market Penetration and Potential Long-Term Growth

Symbols
ALC
Sector(s)
Healthcare
Rating
Current Price
$78.77
Fair Value
Economic Moat
Stewardship
Summary

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoe

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade